UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Elevation of Receptor Tyrosine Kinase EphA2 Mediates Resistance to Trastuzumab Therapy

Cancer research (Chicago, Ill.), 2010-01, Vol.70 (1), p.299-308

2010

Volltextzugriff (PDF)

In vitro and in vivo evaluation of cysteine and site specific conjugated herceptin antibody-drug conjugates

PloS one, 2014-01, Vol.9 (1), p.e83865

2014

Volltextzugriff (PDF)

The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling

The Journal of clinical investigation, 2008-01, Vol.118 (1), p.64-78

2008

Volltextzugriff (PDF)

Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo

Molecular cancer therapeutics, 2007-04, Vol.6 (4), p.1357-1367

2007

Volltextzugriff (PDF)

Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo

Oncogene, 2002-10, Vol.21 (46), p.7011-7026

2002

Volltextzugriff (PDF)

A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth

Molecular carcinogenesis, 2007-06, Vol.46 (6), p.488-496

2007

Volltextzugriff (PDF)

Using the Lessons Learned From the Clinic to Improve the Preclinical Development of Antibody Drug Conjugates

Pharmaceutical Research, 2015-11, Vol.32 (11), p.3458-3469

2015

Volltextzugriff (PDF)

EphA2 Immunoconjugate as Molecularly Targeted Chemotherapy for Ovarian Carcinoma

JNCI : Journal of the National Cancer Institute, 2009-09, Vol.101 (17), p.1193-1205

2009

Volltextzugriff (PDF)

Contribution of Polycomb Homologues Bmi-1 and Mel-18 to Medulloblastoma Pathogenesis

Molecular and Cellular Biology, 2007-07, Vol.27 (13), p.4968-4979

2007

Volltextzugriff (PDF)

1147-D Preclinical characterization of a novel claudin 18.2 targeting-ISAC with robust potency and acceptable safety profile

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 2), p.A1838-A1838

2023

Volltextzugriff (PDF)

EphA2 Targeted Chemotherapy Using an Antibody Drug Conjugate in Endometrial Carcinoma

Clinical cancer research, 2010-05, Vol.16 (9), p.2562-2570

2010

Volltextzugriff (PDF)

Antitumor efficacy of IPI-504, a selective heat shock protein 90 inhibitor against human epidermal growth factor receptor 2–positive human xenograft models as a single agent and in combination with trastuzumab or lapatinib

Molecular cancer therapeutics, 2009-08, Vol.8 (8), p.2131-2141

2009

Volltextzugriff (PDF)

Inhibition of VEGF-Dependent Multistage Carcinogenesis by Soluble EphA Receptors

Neoplasia (New York, N.Y.), 2003-09, Vol.5 (5), p.445-456

2003

Volltextzugriff (PDF)

The Highs, Lows, and Resurgence of Antibody-drug Conjugates

ADC Review / Journal of Antibody-drug Conjugates, 2024-07

Jackson, Dowdy

2024

Volltextzugriff (PDF)

A human antibody-drug conjugate targeting EphA2 inhibits tumor growth in vivo

Cancer research (Chicago, Ill.), 2008-11, Vol.68 (22), p.9367-9374

2008

Volltextzugriff (PDF)

Abstract B013: Site specific conjugation of engineered non-native amino acids in an anti-CD3 Fab-folate bispecific antibody significantly enhances its antitumor properties in gynecologic cancers

Cancer immunology research, 2019-02, Vol.7 (2_Supplement), p.B013-B013

2019

Volltextzugriff (PDF)

Site-Specific Antibody-Drug Conjugates

Innovations for Next-Generation Antibody-Drug Conjugates, 2018, p.241-265

2018

Volltextzugriff (PDF)

Abstract 4399: EphA2-targeting antibody-gelonin conjugate specifically binds and kills target-expressing tumor cells, including multi-drug resistant (MDR) lines

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.4399-4399

2010

Volltextzugriff (PDF)

The insulin-like growth factor II/mannose 6-phosphate receptor is required for proliferin-induced angiogenesis

Endocrinology (Philadelphia), 1996-09, Vol.137 (9), p.3871-3876

1996

Volltextzugriff (PDF)

Stimulation and Inhibition of Angiogenesis by Placental Proliferin and Proliferin-Related Protein

Science (American Association for the Advancement of Science), 1994-12, Vol.266 (5190), p.1581-1584

1994

Volltextzugriff (PDF)

Proliferin Transport and Binding in the Mouse Fetus1

Endocrinology (Philadelphia), 1997-01, Vol.138 (1), p.149-155

1997

Volltextzugriff (PDF)

Proliferin Transport and Binding in the Mouse Fetus 1

Endocrinology (Philadelphia), 1997-01, Vol.138 (1), p.149-155

1997

Volltextzugriff (PDF)

Inhibition of VEGF-Dependent Multistage Carcinogenesis by Soluble EphA Receptors1

Neoplasia (New York, N.Y.), 2003-09, Vol.5 (5), p.445-456

2003

Volltextzugriff (PDF)

Magnetic resonance contrast enhancement of neovasculature with ?v?3-targeted nanoparticles

Magnetic resonance in medicine, 2000-09, Vol.44 (3), p.433-439

2000

Volltextzugriff (PDF)

Proliferin and proliferin related protein and their roles in angiogenesis

Jackson, Dowdy

1996

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(35)

Publikationsform

Sprache

Englisch
(39)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

Science & Technology
(24)
Life Sciences & Biomedicine
(21)
Humans
(16)
Animals
(12)
Female
(12)
Oncology
(12)
Mice
(10)
Cell Line, Tumor
(9)
Biological And Medical Sciences
(8)
Medical Sciences
(7)
Tumors
(7)
Male
(6)
Xenograft Model Antitumor Assays
(5)
Angiogenesis
(4)
Antibodies, Monoclonal - Pharmacology
(4)
Antineoplastic Agents
(4)
Cohort Studies
(4)
Immunoconjugates - Pharmacology
(4)
Medical Prognosis
(4)
Metastasis
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Elevation of Receptor Tyrosine Kinase EphA2 Mediates Resistance to Trastuzumab Therapy

In vitro and in vivo evaluation of cysteine and site specific conjugated herceptin antibody-drug conjugates

The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling

Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo

Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo

A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth

Using the Lessons Learned From the Clinic to Improve the Preclinical Development of Antibody Drug Conjugates

EphA2 Immunoconjugate as Molecularly Targeted Chemotherapy for Ovarian Carcinoma

Contribution of Polycomb Homologues Bmi-1 and Mel-18 to Medulloblastoma Pathogenesis

1147-D Preclinical characterization of a novel claudin 18.2 targeting-ISAC with robust potency and acceptable safety profile

EphA2 Targeted Chemotherapy Using an Antibody Drug Conjugate in Endometrial Carcinoma

Antitumor efficacy of IPI-504, a selective heat shock protein 90 inhibitor against human epidermal growth factor receptor 2–positive human xenograft models as a single agent and in combination with trastuzumab or lapatinib

Inhibition of VEGF-Dependent Multistage Carcinogenesis by Soluble EphA Receptors

The Highs, Lows, and Resurgence of Antibody-drug Conjugates

A human antibody-drug conjugate targeting EphA2 inhibits tumor growth in vivo

Abstract B013: Site specific conjugation of engineered non-native amino acids in an anti-CD3 Fab-folate bispecific antibody significantly enhances its antitumor properties in gynecologic cancers

Site-Specific Antibody-Drug Conjugates

Abstract 4399: EphA2-targeting antibody-gelonin conjugate specifically binds and kills target-expressing tumor cells, including multi-drug resistant (MDR) lines

The insulin-like growth factor II/mannose 6-phosphate receptor is required for proliferin-induced angiogenesis

Stimulation and Inhibition of Angiogenesis by Placental Proliferin and Proliferin-Related Protein

Proliferin Transport and Binding in the Mouse Fetus1

Proliferin Transport and Binding in the Mouse Fetus 1

Inhibition of VEGF-Dependent Multistage Carcinogenesis by Soluble EphA Receptors1

Magnetic resonance contrast enhancement of neovasculature with ?v?3-targeted nanoparticles

Proliferin and proliferin related protein and their roles in angiogenesis

Suchergebnisse filtern